A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2009
11/05/2009	WO2009043526A3 Use of gip ( 6-30) alone or in combination with hgh as a therapeutic agent
11/05/2009	WO2009040051A9 Use of the peptide rfmwmk alone or in combination with the peptide ymdgtmsqv as a therapeutic agent
11/05/2009	WO2009040005A9 Use of the peptide rfmwmr as a therapeutic agent
11/05/2009	WO2009033819A3 Use of glicentin-related polypeptide and apelin- 13 in combination as therapeutic agents, eg for treating aids
11/05/2009	WO2009033797A3 Use of apelin-17 and peptide yy as therapeutic agents, eg for treating hbv infection
11/05/2009	WO2009033785A3 Use of alpha-casein (90-96) as a therapeutic agent in eg the treatment of hiv infection
11/05/2009	WO2009033784A3 Use of apelin-13 (qrprlshkgpmpf) and optionally aplha-casein (90-96) as a therapeutic agents in eg the treatment of hiv infection
11/05/2009	WO2009033738A3 Use of glucagon (1-29) alone or in combination with neuropeptide w30 as a therapeutic agent
11/05/2009	WO2009033712A3 Use of melanotan ii as a therapeutic agent
11/05/2009	WO2009029847A8 Compositions and methods of using proislet peptides and analogs thereof
11/05/2009	WO2009000971A3 Peptide gacfsiahecga for targeting mtl-mmp
11/05/2009	WO2008134020A8 Ccl18 and ccl3 methods and compositions for detecting and treating cancer
11/05/2009	WO2008124166A8 Fusion proteins of collagen-binding domain and parathyroid hormone
11/05/2009	WO2008113536A8 Neurotrophic peptides
11/05/2009	WO2008097503A8 Use of semaphorin 6a for promoting myelination and oligodendrocyte differentiation
11/05/2009	WO2008080035A8 Randomly oriented, fgf-2- modified nanofiber device for use in spinal cord repair
11/05/2009	WO2008036761A8 Anti-microbial defensin-related peptides and methods of use
11/05/2009	WO2008033887A8 Methods for treating cancer
11/05/2009	WO2007117215A8 Binder for c-reactive protein
11/05/2009	WO2007112345A8 Use of cyclosporin alkene analogues for preventing or treating viral-induced disorders
11/05/2009	US20090276863 Protein formulations comprising s1-5
11/05/2009	US20090275877 Method of Enhancing Electrotransport Polypeptide Flux By Amino Acid Substitution with Histidine
11/05/2009	US20090275738 Use of A33 antigens and jam-it
11/05/2009	US20090275735 Monoclonal antibodies to human ctla-8 (il-17a)
11/05/2009	US20090275664 Novel polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
11/05/2009	US20090275645 Method to induce neovascular formation and tissue regeneration
11/05/2009	US20090275644 Novel adaptor protein that binds to mammalian toll-like receptor 3 and gene thereof
11/05/2009	US20090275643 Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis
11/05/2009	US20090275523 Spirocyclic nitriles as protease inhibitors
11/05/2009	US20090275522 Novel Compounds
11/05/2009	US20090275521 Regulation of Microphage Migration Inhibitory Factor (MIF) Activity
11/05/2009	US20090275520 Mucin hypersecretion inhibitors and methods of use
11/05/2009	US20090275519 Therapeutic peptidomimetic macrocycles
11/05/2009	US20090275518 G-csf polypeptides and uses thereof
11/05/2009	US20090275517 G-csf polypeptides and uses thereof
11/05/2009	US20090275516 Compounds and method for modulating inflammatory reactions
11/05/2009	US20090275515 2-hydroxy-2-phenylthiophenylpropionamides as androgen receptor modulators
11/05/2009	US20090275514 Use of calmodulin kinase ii inhibitors to treat or prevent heart muscle inflammation
11/05/2009	US20090275513 Composition and method for preparing plasminogen
11/05/2009	US20090275512 Compositions and methods for treating cardiovascular disease and myocardial infarction with dipeptidyl peptidase inhibitors or b type natriuretic peptide analogues resistant to prolyl-specific dipeptidyl degradation
11/05/2009	US20090275511 Analogs of ghrelin substituted at the n-terminal
11/05/2009	US20090275510 Compositions and Methods for Inducing or Inhibiting Activities of Selected Human Cells
11/05/2009	US20090275509 Method for stimulating angiogenesis using dkk2 and composition comprising the same
11/05/2009	US20090275508 Use of thymosin alpha 1, alone or in combination with ptx3 or ganciclovir, for the treatment of cytomegalovirus infection
11/05/2009	US20090275507 Contraceptive composition
11/05/2009	US20090275506 Long lasting natriuretic peptide derivatives
11/05/2009	US20090275505 Compositions and Methods For Preventing or Treating Feline Chronic Renal Failure
11/05/2009	US20090275504 Pcsk9 proteins, fragments thereof and methods of modulating pcsk9 phosphorylation and low density lipoprotein (ldlr) degradation
11/05/2009	US20090275503 Diastereomeric peptides for modulating t cell immunity
11/05/2009	US20090275502 Methods and compositions for enhancing developmental potential of oocytes and preimplantation embryos
11/05/2009	US20090275501 Somatostatin-dopamine chimeric analogs
11/05/2009	US20090275500 Peptide-containing food intake regulator
11/05/2009	US20090275499 Nonstructural protein ns1 as a novel therapeutic target against flaviviruses
11/05/2009	US20090275498 Novel peptides
11/05/2009	US20090275497 Method for identifying modulators of the activity of ion-channels receptors
11/05/2009	US20090275496 Effective quantitation of complex peptide mixtures in tissue samples and improved therapeutic methods
11/05/2009	US20090275495 Methods and compositions relating to alzheimer's disease
11/05/2009	US20090275134 Compositions of active wnt protein
11/05/2009	US20090275133 Antisense modulation of c-reactive protein expression
11/05/2009	US20090275123 Modified vitamin k-dependent polypeptides
11/05/2009	US20090275106 Polynucleotide encoding A polypeptide having heparanase activity and expression of same in genetically modified cells
11/05/2009	US20090275041 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
11/05/2009	US20090275024 Novel centrerosome-associated protein and applications thereof
11/05/2009	US20090274770 Cellular extracts
11/05/2009	US20090274759 Solid pharmaceutical composition with a first fraction of a dispersion medium and a second fraction of a matrix, the latter being at least partially first exposed to gastrointestinal fluids
11/05/2009	US20090274758 Solid Composition for Intra-Oral Delivery of Insulin
11/05/2009	US20090274746 Methods and compositions for controlled delivery of phytochemical agents
11/05/2009	US20090274737 Implant comprising a surface of reduced thrombogenicity
11/05/2009	US20090274736 Nutraceutical Compositions From Microalgae And Related Methods of Production And Administration
11/05/2009	US20090274734 Method for obtaining hollow particles
11/05/2009	US20090274730 Compositions and methods for treating inflammation
11/05/2009	US20090274718 Chimeric proteins that induce effects directed against viruses
11/05/2009	US20090274715 Tick chitinase
11/05/2009	US20090274714 Tumour-associated peptides binding to human leukocyte antigen (hla) class i or ii molecules and related anti-cancer vaccine
11/05/2009	US20090274708 Recombinant Toxin Fragments
11/05/2009	US20090274707 Anti-IL-12 Antibodies, Nucleic Acids Encoding Antibodies, and Methods of Production
11/05/2009	US20090274703 Methods of treating inflammation using IL-17 antagonists
11/05/2009	US20090274701 Chlamydia pneumoniae polynucleotides and uses thereof
11/05/2009	US20090274699 Ul16 binding protein 4
11/05/2009	US20090274696 Methods for treating inflammation
11/05/2009	US20090274694 Cytokine receptor zcytor17 multimers
11/05/2009	US20090274690 Stimulating remyelination of central nervous system axons by administering a monoclonal antibody characterized by their ability to bind structures and cells within the central nervous system, including oligodendrocytes; including neural dysfunction caused by spinal cord injury
11/05/2009	US20090274689 For improving clinical outcome in focal ischemic stroke in a mammal by increasing cerebral blood flow and/or reducing infarct size in absence of removal of the arterial obstruction
11/05/2009	US20090274688 Antibodies to OPGL
11/05/2009	US20090274687 Attenuation of hypoxia induced cardiovascular disorders
11/05/2009	US20090274683 Adamts13 genes and proteins and variants, and therapeutic compositions and methods of utilizing the same
11/05/2009	US20090274682 Demethylation and inactivation of protein phosphatase 2a
11/05/2009	US20090274681 Novel gene encoding a dna repair enzyme and methods of use thereof
11/05/2009	US20090274680 Human Phospholipases
11/05/2009	US20090274679 Production and use of human butyrylcholinesterase
11/05/2009	US20090274678 Compositions and methods to treat urinary incontinence
11/05/2009	US20090274677 Antioxidant for use in cosmetic, medicated and pharmaceutical preparations
11/05/2009	US20090274670 Dph2 gene deletion mutant and uses thereof
11/05/2009	US20090274668 Combined Regulation of Neural Cell Production
11/05/2009	US20090274666 B7-h1, a novel immunoregulatory molecule
11/05/2009	US20090274658 Tight Junction Modulating Peptides for Enhanced Mucosal Delivery of Therapeutic Compounds
11/05/2009	US20090274657 Difluoromethyl-containing macrocyclic compounds as hepatitis c virus inhibitors
11/05/2009	US20090274656 Hepatitis c virus inhibitors
11/05/2009	US20090274655 2-carboxy thiophene derivatives as anti viral agents
11/05/2009	US20090274654 Methods and devices for the sustained release of multiple drugs

1 ... 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 ... 3163